BRIEF-Endocyte form 4 discloses CEO's 44,285 stock options fully vested on May 31, immediately exercisable

* Endocyte Inc form 4 discloses that CEO Michael Sherman's 44,285 stock options (right to buy) fully vested on may 31 and immediately exercisable - sec filing Source text (http://bit.ly/2rytsCJ) Further company coverage:

by reutersCOMPANYNEWS via Endless Supplies .Biz - News